INTRODUCTION {#h0.0}
============

IS*26*, which was first described over three decades ago ([@B1]), is a member of the IS*6* family ([@B2]), and IS*26* may be identical to IS*6*, which has never been sequenced. IS*26* was present in many early antibiotic-resistant isolates and was given several other names: IS*15*Δ, IS*46*, IS*140*, IS*160*, IS*176*, and IS*1936* ([@B3][@B4][@B8]). However, these ISs are now known to be identical ([@B3], [@B9]). IS*26* plays a critical role in the dissemination of antibiotic resistance genes in Gram-negative bacteria, as it is associated with genes conferring resistance to many different classes of antibiotics (for example, see references [@B7], [@B8], and [@B10][@B11][@B20]) or partial class 1 integrons ([@B21]). IS*26* is known to be able to contribute to the expression of the associated resistance gene by supplying a promoter −35 box that can be coupled with a −10 in the adjacent DNA ([@B14], [@B22]).

Antibiotic resistance genes flanked by IS*26*s resemble class I or composite transposons, which consist of two ISs flanking a central segment. In most cases, the IS*26*s are in a direct orientation. However, structures containing more than two IS*26*s exhibit a feature that is not consistent with this designation because they include multiple putative composite transposons (IS*26*-unique segment-IS*26*) in an array that contains too few copies of the IS ([@B11]). That is, the adjacent putative transposons share a single IS*26* located between them. An example of two overlapping IS*26*-bounded structures, each of which is also found alone, has been found in several locations ([@B11]). Further examples of these arrays are found in many complex regions containing several different antibiotic resistance genes (for examples, see references [@B11], [@B15], and [@B23][@B24][@B25]). The arrangement is shown schematically in [Fig. 1A](#fig1){ref-type="fig"}. This configuration cannot be explained if the individual "transposons" move in the same way as the well-studied composite transposons Tn*5* and Tn*10* ([@B26], [@B27]), which move as a single discrete unit. Duplication of IS*26*-flanked structures detected after the selective pressure of antibiotic use has also been reported, and this leads to the formation of tandem arrays ([Fig. 1B](#fig1){ref-type="fig"}) of the same DNA fragment interspersed with directly oriented copies of IS*26* ([@B28][@B29][@B31]).

![Configuration of regions containing multiple copies of IS*26*. (A) Different IS*26*-flanked DNA segments clustered, with insufficient copies of IS*26* for the unit of mobilization to be a typical class I transposon. IS*26*s are represented as boxes with a horizontal arrow indicating the position and orientation of *tnp26*. Thick horizontal lines with numbers above denote different segments of DNA. The extents of potential overlapping transposon forms ("Tn") are indicated above, and hypothetical translocatable units (TU) are shown below. (B) A single IS*26*-flanked DNA segment in a multimeric array.](mbo0051420190001){#fig1}

IS*26* ([Fig. 2](#fig2){ref-type="fig"}) is 820 bp long, with 14-bp perfect terminal inverted repeats and a single gene, *tnp26*, that encodes a transposase (Tnp26) of 234 amino acids (aa) ([@B1]). IS*26* has been shown to form a cointegrate between the DNA molecule it resides in and the target molecule, but whether transposition via a cut-and-paste mechanism can also occur has not been investigated. In cointegrates, the IS*26* is duplicated, resulting in two copies of IS*26* in direct orientation, one at each boundary between the two participating molecules. Transposition generates an 8-bp duplication of the target site, which is found flanking the incoming molecule ([@B32], [@B33]). IS*15* and IS*15*Δ have been shown to function in the same manner ([@B34], [@B35]). In these studies, resolution of cointegrates was only seen in strains that were proficient for homologous recombination.

![IS*26* schematic. The horizontal arrow shows the position and orientation of *tnp26*. Short vertical lines indicate the locations of the conserved amino acids in the DDE triad, and longer vertical lines indicate the locations of restriction sites. IR~L~ and IR~R~ mark the IS*26* left and right inverted repeats, respectively.](mbo0051420190002){#fig2}

Despite the prevalence of IS*26* in the resistance gene clusters of antibiotic-resistant Gram-negative bacteria, transposition of IS*26* has not been further examined since the 1980s. Consequently, the mechanism behind IS*26*-mediated mobilization of resistance genes has not been explored. In order to better understand IS*26*-mediated mobilization of resistance genes in Gram-negative bacteria and the impact that it has on the evolution of multiple antibiotic resistance in bacterial populations, we have proposed a model to explain the structures observed. A standard conduction assay was then used to experimentally demonstrate that IS*26* movement exhibits some of the properties predicted by this model.

RESULTS {#h1}
=======

Model for movement of IS*26*-associated DNA segments containing antibiotic resistance genes. {#h1.1}
--------------------------------------------------------------------------------------------

To account for the observed structures with an IS*26* shared between two adjacent apparent class I transposons and for the formation of tandem arrays shown in [Fig. 1](#fig1){ref-type="fig"}, we propose the model shown in [Fig. 3](#fig3){ref-type="fig"} in which the unit of mobility is a single copy of the IS together with a unique DNA segment. To clearly distinguish this unit from a class I transposon, we will call it a "translocatable unit" (TU). In the model, the IS*26* in the TU targets an existing copy of IS*26* and the TU is incorporated immediately adjacent to it without increasing the number of IS*26* copies or creating a further duplication of the target. This model predicts the preferential interaction of two IS*26*s and that the process is conservative (i.e., duplication of IS*26* and of the target site does not occur in this mode).

![Mechanism of IS*26* mobilization. IS*26*s are shown as open boxes, with an arrow indicating the position and orientation of *tnp26*. Arrows give orientation to the central gene fragment. Flags indicate the position and direction of duplications formed from the insertion of IS*26*.](mbo0051420190003){#fig3}

Movement of IS*26*. {#h1.2}
-------------------

All experiments were conducted in a *recA* mutant *Escherichia coli* background to ensure that the events detected had been catalyzed by the IS*26*-encoded transposase Tnp26. First, the ability of a single copy of IS*26* to form cointegrates as described previously was confirmed using a mating-out assay to detect the cointegrates formed between the plasmid pRMH762 (which confers ampicillin resistance \[Ap^r^\]), which contains a single IS*26*, and the conjugative plasmid R388 (which confers sulfonamide and trimethoprim resistance \[Su^r^ Tp^r^\]) residing together in the *E. coli recA* mutant background. The Ap^r^ Tp^r^ transconjugants carrying cointegrates were detected at an average of 2.9 × 10^−6^ cointegrates per Tp^r^ transconjugant ([Table 1](#tab1){ref-type="table"}). Digestion of several independent cointegrates with BglII and BsiWI mapped the location of the junctions between the two plasmids and showed that pRMH762 had incorporated randomly throughout the R388 backbone ([Fig. 4](#fig4){ref-type="fig"}). The precise boundaries between the two plasmids relative to one another were determined for 10 cointegrates using primers in the R388 backbone adjacent to the predicted cointegrate boundaries with primers internal to pRMH762 (RH1451 and RH1452) to amplify each boundary. Both orientations of the plasmids relative to one another were found. The sequence spanning each IS*26* revealed that a copy of IS*26* was found in direct orientation at each boundary, and a duplication of 8 bp of R388 had been generated.

###### 

Transposition frequency of pRM762 and derivatives

  Plasmid   IS*26*                          Target                                 Transposition frequency^[*a*](#ngtab1.1)^        
  --------- ------------------------------- -------------------------------------- ------------------------------------------- ---- ---------------------------------
  pRMH762   IS*26*                          R388                                   2.9 × 10^−6^                                10   1.3 × 10^−6^--5.1 × 10^−6^
  pRMH962   IS*26*-FS-L^[*c*](#ngtab1.3)^   R388                                   \<1.9 × 10^−8^                              3    \<2.9 × 10^−9^-- \<5.4 × 10^−8^
  pRMH762   IS*26*                          R388::IS*26*                           1.8 × 10^−4^                                10   5.4 × 10^−5^--4.7 × 10^−4^
  pRMH962   IS*26-*FS-L                     R388::IS*26*                           5.9 × 10^−6^                                3    5.8 × 10^−6^--7.5 × 10^−6^
  pRMH762   IS*26*                          R388::IS*26*-FS--R^[*d*](#ngtab1.4)^   4.3 × 10^−6^                                3    3.9 × 10^−6^--4.9 × 10^−6^
  pRMH962   IS*26*-FS-L                     R388::IS*26*-FS--R                     \<3.5 × 10^−9^                              3    \<2.4 × 10^−9^-- \<5.1 × 10^−9^

Transposition frequency expressed as cointegrates per transconjugant.

Number of independent determinations.

IS*26*-FS-L, frameshift mutation in pRMH762 IS*26 tnp26*.

IS*26*-FS--R, frameshift mutation in R388::IS*26 tnp26.*

![Cointegrate formation between pRMH762 and R388. The R388 backbone is drawn to scale from GenBank accession no. [BR000038](BR000038) with key resistance genes, genes involved in replication (*repA*), and genes involved in conjugative transfer (*tra*) shown as arrows inside the circular backbone. Arrows pointing toward the circular backbone indicate the location of 20 mapped R388::pRMH762 cointegrates. The precise location and orientation of nine cointegrates were determined by sequencing. An arrow labeled 1 indicates a cointegrate with *tnp26* facing clockwise, while an arrow labeled 2 indicates a cointegrate with *tnp26* facing counterclockwise. An asterisk denotes the cointegrate used in the construction of R388::IS*26*.](mbo0051420190004){#fig4}

To confirm the requirement for Tnp26, pRMH962 (Ap^r^), a derivative of pRMH762 with a frameshift at the left end of the IS*26* transposase gene (BsiWI site in [Fig. 2](#fig2){ref-type="fig"}) that would truncate the 234-aa transposase to a 30-aa protein was also examined. Cointegrate formation between R388 and pRMH962 was not detected in three independent experiments ([Table 1](#tab1){ref-type="table"}).

TUs target IS*26*. {#h1.3}
------------------

In the cointegration assay, the small plasmid carrying IS*26* can be viewed as a TU that has the capacity to replicate. To examine the prediction that when a second copy of IS*26* is present it acts as a preferred target, the conjugative plasmid was replaced with R388::IS*26* containing a single copy of IS*26*. The location of this IS is indicated by an asterisk in [Fig. 4](#fig4){ref-type="fig"}. Cointegrates formed between pRMH762 and R388::IS*26* were recovered at an average frequency of 1.78 × 10^−4^ per R388::IS*26* transconjugant ([Table 1](#tab1){ref-type="table"}), and this represents a 60-fold increase in transposition frequency compared to when R388 was the target. Mapping of plasmid DNA extracted from 20 Ap^r^ Tp^r^ transconjugants (2 from each of 10 independent experiments) revealed that they all produced the same restriction pattern, and this corresponded to the pattern expected if incorporation of pRMH762 (the TU) had occurred adjacent to the IS*26* in R388::IS*26.*

The position of the cointegrate junctions was confirmed and the orientation determined using primer pairs RH1471/RH1452 and RH1472/RH1451 to link the R388 backbone across each IS*26* into the pRMH762-derived region ([Fig. 5](#fig5){ref-type="fig"}). PCR products of the expected size (1,464 bp and 1,042 bp, respectively) confirmed that all of the tested cointegrates shared the same boundaries between pRMH762 and R388::IS*26*, and the IS*26*s were always in the direct orientation. The sequences of the PCR amplicons showed that, in every case, the direct repeats flanking the single IS*26* in R388::IS*26* were now located next to the left and right ends of the IS*26-*flanked pRMH762 and the direct repeats surrounding the IS*26* in pRMH762 were at the internal boundaries ([Fig. 5](#fig5){ref-type="fig"}). Hence, the incorporation of pRMH762 adjacent to the IS*26* in R388::IS*26* did not generate an additional copy of IS*26* or a duplication of a target sequence (i.e., the reaction was conservative).

![Targeted cointegrate formation between R388::IS*26* and pRMH762. Open boxes are IS*26*s, and the horizontal arrows indicate the position and orientation of *tnp26*. Open flags denote the 8-bp direct repeat of bases 26745 to 26752 in R388 (GenBank accession no. [BR000038](BR000038)). Solid flags denote the 8-bp direct repeat flanking Tn*4352*B in GenBank accession no. [KF976462](KF976462). The locations of primers used to map targeted cointegrates are shown. Note that the figure is not to scale.](mbo0051420190005){#fig5}

High-frequency recombination between two IS*26*s requires an active Tnp26 produced by both IS*26*s. {#h1.4}
---------------------------------------------------------------------------------------------------

To determine whether an active Tnp26 transposase must be produced by both copies of IS*26* participating in the reaction, cointegrate formation between R388::IS*26* and pRMH962 (with a frameshift in *tnp26*) was measured, and Ap^r^ Tp^r^ transconjugants were recovered at a frequency of 2.5 × 10^−6^/Tp^r^ transconjugant ([Table 1](#tab1){ref-type="table"}). This represents a 30-fold decrease in efficiency compared to when both IS*26*s are intact. However, restriction mapping of a cointegrate from each of five independent experiments produced the same restriction pattern, indicating that the IS*26* in R388::IS*26* remained the preferred target.

To perform the reciprocal experiment, a frameshift was introduced into the *tnp26* gene of R388::IS*26* at the position of the SwaI site in [Fig. 2](#fig2){ref-type="fig"}, to generate R388::IS*26*-FS--R producing an inactivated Tnp26. Cointegrates were formed between pRMH762 and R388::IS*26*-FS--R at a frequency of 1.8 × 10^−6^ cointegrates per transconjugant ([Table 1](#tab1){ref-type="table"}), and this is similar to that seen between pRMH962 (IS*26*-FS-L) and R388::IS*26*. Again, mapping of five independent cointegrates produced the same restriction pattern. However, cointegrate formation was not detected when the participating plasmids were pRMH962 (IS*26*-FS-L) and R388::IS*26*-FS--R, both of which contain an IS with a frameshift in *tnp26* ([Table 1](#tab1){ref-type="table"}), confirming the requirement for Tnp26.

Does only one end of IS*26* participate in the reaction? {#h1.5}
--------------------------------------------------------

One possible way in which the targeting could be achieved is if Tnp26 preferentially binds to one end of IS*26* and the recombination reaction occurs at that end of the IS. In the experiments using a plasmid containing a frameshift in the *tnp26* gene of only one IS*26* copy, it was possible to use unique features introduced during the generation of the frameshifts to explore this possibility by determining the origin of each IS*26* (L and R in [Fig. 5](#fig5){ref-type="fig"}) in each cointegrate. In R388::IS*26*-FS--R, the unique SwaI site of IS*26* ([Fig. 2](#fig2){ref-type="fig"}) has been removed, and both of the IS*26*s in 10 independent cointegrates recovered from pRMH762 recombination with R388::IS*26*-FS--R were amplified by PCR and digested with SwaI. In 7 of the 10 cointegrates tested, the intact IS*26* was located on the left ([Fig. 5](#fig5){ref-type="fig"}) and the IS*26* containing a frameshift was located on the right. In the remaining cointegrates, the opposite was observed.

In pRMH962, digestion at the BsiWI site ([Fig. 2](#fig2){ref-type="fig"}) followed by end filling and religation generated a unique SnaBI site (TACGTA) at bases 116 to 121 of the mutant IS*26* that is not present in the intact IS*26*. The two IS*26*s in 10 independent cointegrates recovered from crossing pRMH962 with R388::IS*26* were PCR amplified, and the products were digested with SnaBI. In 6 out of the 10 cointegrates tested, the intact IS*26* was located on the left and the IS*26* containing the frameshift was located on the right. In the remaining cointegrates, the locations were reversed. Hence, the reaction does not appear to occur at one end of the IS.

Transfer of a TU. {#h1.6}
-----------------

The experiments thus far have shown targeted incorporation of the IS*26*-containing plasmid pRMH762, which is essentially acting as a TU. Our model of IS*26*-mediated mobilization of resistance genes predicts that a TU should be able to form from an IS*26*-flanked structure and insert adjacent to another IS*26*. To detect TU movement, pRMH761 ([Fig. 6A](#fig6){ref-type="fig"}), which is the parent of pRMH762 and contains Tn*4352*B (IS*26*-*aphA1a*-IS*26*) conferring resistance to kanamycin and neomycin (Km^r^ Nm^r^), was introduced into DH5α with R388::IS*26*. While Ap^r^ Km^r^ Tp^r^ cointegrates would be recovered if the complete pRMH761 was incorporated into R388::IS*26*, incorporation of only the TU should generate Km^r^ Tp^r^ cointegrates that are ampicillin susceptible (Ap^s^) ([Fig. 6B](#fig6){ref-type="fig"}). Km^r^ Tp^r^ transconjugants were recovered, and among 100 colonies tested, only one was Ap susceptible. Three further Ap^s^ Km^r^ Tp^r^ transconjugants were recovered from two additional experiments.

![Direct transfer of a TU from pRMH761 into R388::IS*26*. The reaction between the two plasmids in the donor cell (A) should form four possible products (B to D). (B) TU*aphA1* alone incorporated into R388::IS*26*. (C and D) cointegrates formed between R388::IS*26* and pRMH762 (C) or the complete pRMH761 (D1 and D2). IS*26*s are shown as open boxes, with an arrow indicating the orientation of *tnp26*. Open flags denote the 8-bp direct repeat of bases 26745 to 26752 in R388 (GenBank accession no. [BR000038](BR000038)). Solid flags denote the 8-bp direct repeat flanking Tn*4352*B in GenBank accession no. [KF976462](KF976462). The location of primers used to map targeted cointegrates is shown by bent arrows. The phenotypes of recipient cells containing the plasmids shown are also indicated, and Tp^r^ strains are also Su^r^. Note that the figure is not to scale.](mbo0051420190006){#fig6}

Mapping confirmed that in plasmids recovered from these transconjugants, Tn*4352*B now replaced the single IS*26* in R388::IS*26*. Recovery of this transposon-like structure (Tn*4352*B) is indicative of movement of only one IS*26* and the *aphA1*-containing segment. Plasmid DNA from these transconjugants was also amplified with the R388 backbone primers RH1471 and RH1472 combined with primers aphA1-F and aphA1-R internal to *aphA1a* (see [Fig. 6B](#fig6){ref-type="fig"} for primer locations), and the sequences of the products confirmed that the *aphA1a*-containing TU (TU*aphA1a*) had been inserted adjacent to the IS*26* in R388::IS*26*. Again, the two IS*26*s were in direct orientation separated by the unique portion of the incoming TU*aphA1a*, and no further duplication of the target sequence had occurred. An amplicon of 3.4 kb was generated with primers RH1471/RH1472, demonstrating that only a single copy of the TU had inserted adjacent to the IS*26* ([Fig. 6B](#fig6){ref-type="fig"}).

Ap^r^ Tp^r^ transconjugants were also screened for growth on media containing kanamycin to distinguish Km^r^ cointegrates with the complete pRMH761 incorporated ([Fig. 6D1 and D2](#fig6){ref-type="fig"}) from Km^s^ ones with only the equivalent of pRMH762 ([Fig. 6C](#fig6){ref-type="fig"}). Of the 100 Ap^r^ Tp^r^ cointegrates examined, 43 were also resistant to kanamycin (Km^r^). Mapping of 10 Ap^r^ Km^r^ Tp^r^ cointegrates revealed that the incoming plasmid was next to the preexisting IS*26* in R388::IS*26*, and both D1 ([@B6]) and D2 ([@B4]) configurations were formed. The greater abundance of the Ap^r^ Tp^r^ Km^s^ product compared to R388::Tn*4352*B may be explained if the *aphA1a* TU can excised from pRMH761 to yield pRMH762, which can replicate, and the free form of TU*aphA1a*, which cannot replicate. It is also possible that TU*aphA1a* can be excised from the cointegrates D1 and D2 formed with R388. Further work will be needed to explore this.

The DDE residues of Tnp26 are required for activity. {#h1.7}
----------------------------------------------------

A conserved DDE motif in IS*6* family transposases was predicted by Mahillon and Chandler ([@B2]), and alignments between the Tnp26 and the transposases of other family members confirmed that they are conserved in this family. This amino acid triad coordinates divalent metal cations, making it essential for activity. However, these residues have not been shown to be essential for Tnp26 activity. The codons for the aspartic acid (D) residues at positions 82 and 142 of Tnp26 and the glutamic acid (E) residue at position 177 were altered in the IS*26*-containing plasmid pRMH977 (Ap^r^), causing a leucine substitution. The clones generated, pRMH987, pRMH988, and pRMH989, respectively, were each tested for the ability to form cointegrates with the conjugative plasmid R388. No Ap^r^ Sm^r^ Tp^r^ colonies were recovered from three independent determinations for each clone ([Table 2](#tab2){ref-type="table"}), which is indicative of the inability to form cointegrates when any residue of the DDE motif is altered. However, the parent plasmid pRMH977 formed cointegrates with R388 at a very low frequency (25-fold lower than pRMH762). A higher frequency of 2.14 × 10^−4^ cointegrates per transconjugant was obtained with R388::IS*26*. When the derivatives of pRMH977 producing Tnp26 with LDE, DLE, or DDL were tested with R388::IS*26* ([Table 2](#tab2){ref-type="table"}), the cointegration frequency of 6.4 × 10^−6^ to 8.4 × 10^−6^ was about 25-fold lower and equivalent to that of the *tnp26* frameshift mutant, pRMH978, which formed 8.35 × 10^−6^ cointegrates per transconjugant. Hence, the DDE residues are essential for Tnp26 activity.

###### 

Transposition frequencies of DDE mutants

  Plasmid   IS*26*                          Target         Transposition frequency^[*a*](#ngtab2.1)^       
  --------- ------------------------------- -------------- ------------------------------------------- --- --------------------------------
  pRMH977   IS*26*                          R388           1.7 × 10^−7^                                3   5.1 × 10^−8^--3.7 × 10^−7^
  pRMH978   IS*26*-FS-L^[*c*](#ngtab2.3)^   R388           \<1.8 × 10^−8^                              3   \<1.1 × 10^−8^--\<1.9 × 10^−8^
  pRMH987   IS*26* D82L                     R388           \<5.3 × 10^−8^                              3   \<4.3 × 10^−8^--\<7.1 × 10^−8^
  pRMH988   IS*26* D142L                    R388           \<3.4 × 10^−9^                              3   \<2.8 × 10^−9^--\<4.2 × 10^−9^
  pRMH989   IS*26* E177L                    R388           \<4.4 × 10^−8^                              3   \<1.8 × 10^−8^--\<5.9 × 10^−8^
  pRMH977   IS*26*                          R388::IS*26*   2.1 × 10^−4^                                3   1.9 × 10^−4^--2.4 × 10^−4^
  pRMH978   IS*26*-FS-L^[*c*](#ngtab2.3)^   R388::IS*26*   8.4 × 10^−6^                                3   7.3 × 10^−6^--9.2 × 10^−6^
  pRMH987   IS*26* D82L                     R388::IS*26*   6.4 × 10^−6^                                3   4.8 × 10^−6^--9.6 × 10^−6^
  pRMH988   IS*26* D142L                    R388::IS*26*   6.4 × 10^−6^                                3   3.5 × 10^−6^--1.1 × 10^−5^
  pRMH989   IS*26* E177L                    R388::IS*26*   9.7 × 10^−6^                                3   4.3 × 10^−6^--2.0 × 10^−5^

Transposition frequency expressed as cointegrates per transconjugant.

Number of independent determinations.

IS*26*-FS-L is an IS*26 tnp26* frameshift mutant.

DISCUSSION {#h2}
==========

The model presented here for the movement of IS*26* together with a unique DNA segment explains how regions containing several copies of IS*26* interspersed with different DNA segments containing antibiotic resistance genes or other genes arise. It also explains how the configuration of the tandem duplications that have been reported ([Fig. 1B](#fig1){ref-type="fig"}) are likely to have arisen. Moreover, the predictions of the model were able to be verified experimentally. Consequently, there are two distinct modes of movement for IS*26*. The first is cointegrate formation with duplication of the IS*26* and generation of a target duplication, and the second is TU incorporation at an existing IS*26* ([Fig. 7](#fig7){ref-type="fig"}). This feature is presumably shared by other members of the IS*6* family, setting this IS family apart from other IS with DDE transposases.

![Two routes to cointegrate formation: random and targeted. The IS*26*s (boxes with an arrow indicating the orientation of the *tnp26* gene) in both plasmids are flanked by an 8-bp duplication indicated by a raised arrowhead (solid for the small plasmid and open for R388::IS*26*). The frequency of cointegrate formation is indicated on the arrows (cointegrates/transconjugant).](mbo0051420190007){#fig7}

An intriguing aspect of the results presented here is the finding that a cointegrate with identical features is the end product of both low-frequency IS*26* transposition (when only one participating molecule carries an IS) and high-frequency transposition (when both participating molecules carry an IS) ([Fig. 7](#fig7){ref-type="fig"}). The DDE residues of Tnp26 were clearly essential for both types of transposition activity. Although precisely how the conservative Tnp26-catalyzed reaction seen here is performed remains to be worked out and evidence for TU excision is needed, it is clear that IS*26* differs from all of the ISs examined in detail to date ([@B2], [@B36]).

We have also demonstrated the introduction of Tn*4352*B into R388 via a multistep process that requires the initial formation of R388 carrying IS*26* and either excision of the TU*aphA1a* prior to its incorporation or excision of pRMH762 from a cointegrate. This provides the first evidence for TU formation in a RecA-independent manner. A recent report also observed RecA-independent incorporation of an IS*26-bla*~SHV~ TU into pACYC184 carrying IS*26* but not into pACYC184 ([@B30]). However, details such as the Tnp26 dependence have not been reported, and the excision step requires more detailed investigation.

It seems likely that our model will also apply to other ISs in the IS*6* family, such as IS*257* (also known as IS*431*) and IS*1216*, both of which are associated with the mobilization of antibiotic resistance genes ([@B37], [@B38]). IS*257* ([@B39]) is of particular interest granted its role in the dissemination of resistance genes in staphylococci ([@B40], [@B41]). IS*257* has been shown to be active and to duplicate itself and create an 8-bp target when only one participating molecule contains the IS, but it reacts conservatively when both participants carry IS*257* ([@B41]). Although the strains used were not recombination deficient and a role for Tnp257 is implied rather than proven, these observations support the general applicability of the model within the IS*6* (IS*26*) family.

MATERIALS AND METHODS {#h3}
=====================

Bacterial strains and media. {#h3.1}
----------------------------

*Escherichia coli* DH5α (*supE44* Δ*lacU169* \[ϕ80 *lacZ*ΔM15\] *hsdR17 recA1 endA1 gyrA96 thi-1 relA1*) was used to propagate plasmids. *E. coli* UB1637 (*lys his trp lac recA* Sm^r^) was used as a recipient in transposition experiments. Bacteria were routinely cultured at 37°C in Luria-Bertani (LB) medium or on LB agar. Mueller-Hinton agar was used to select for resistance to trimethoprim. Antibiotics (Sigma) were added at the indicated concentrations: ampicillin, 100 µg ml^−1^; kanamycin, 50 µg ml^−1^; nalidixic acid, 25 µg ml^−1^; streptomycin, 25 µg ml^−1^; and trimethoprim, 25 µg ml^−1^.

DNA manipulation. {#h3.2}
-----------------

Plasmid DNA was isolated by alkaline lysis ([@B11]). DNA was digested with restriction enzymes according to the manufacturer's instructions, and fragments were separated through 0.7% agarose (Bioline) in 1 × Tris-acetate-EDTA (TAE) buffer. The size standards were a 1-kb ladder and λ DNA-HindIII (New England Biolabs).

PCRs were performed as previously described ([@B11]). The sequences for all primers used in this study are listed in [Table 3](#tab3){ref-type="table"}. PCR products were purified for sequencing via gel extraction using an EconoSpin DNA column (Epoch Life Sciences). Routine sequencing was performed at the Australian Genome Research Facility (Sydney).

###### 

Primers used in this study

  Primer                     Sequence (5′→3′)
  -------------------------- -----------------------------------------
  RH1451^[*a*](#ngtab3.1)^   TTCGGT[GGATCC]{.ul}ACCCAGATACGGCTGATGTC
  RH1452^[*a*](#ngtab3.1)^   CACACG[GGATCC]{.ul}TTCGTTCCTGGTCGATTTTC
  RH1453                     TCGATAGATTGTCGCACCTG
  RH1454                     CTGCCTCGGTGAGTTTTCTC
  RH1456^[*b*](#ngtab3.2)^   GTGGCACATG**CTT**GAAACCTACGTGAAG
  RH1457^[*b*](#ngtab3.2)^   CTTCACGTAGGTTTC**AAG**CATGTGCCAC
  RH1458^[*c*](#ngtab3.3)^   CAACGTGATT**CTA**TGCGATCATGG
  RH1459^[*c*](#ngtab3.3)^   CCATGATCGCA**TAG**AATCACGTTG
  RH1471                     CCGCTCCAAAAACTATCCAC
  RH1472                     ATCGGAAATGGTTGTGAAGC
  RH1476^[*b*](#ngtab3.2)^   GATTCATCAACACG**TTG**AAAGCGCCGCC
  RH1477^[*b*](#ngtab3.2)^   GGCGGGCGCTTTC**AAC**GTGTTGATGAATC
  aphA1-F                    CAACGGGAAACGTCTTGCTC
  aphA1-R                    ATTCGTGATTGCGCCTGAG

Underlined sequence indicates BamHI restriction site incorporated into the 5′ end of the primer.

Bold sequence denotes modification to the template sequence to introduce a D→L amino acid substitution.

Bold sequence denotes modification to the template sequence to introduce an E→L amino acid substitution.

Cloning was performed as previously described ([@B11]), with minor modifications. All ligations were performed at a 3:1 M ratio of insert to vector with 40 U of T4 DNA ligase (New England Biolabs) in a final concentration of 1× ligase buffer. Chemically competent *E. coli* DH5α cells were prepared using a CaCl~2~ method, and transformation was performed via heat shock.

Plasmid construction. {#h3.3}
---------------------

The plasmids used in this study are listed in [Table 4](#tab4){ref-type="table"}. pRMH762 is an Ap^r^ Km^s^ derivative of pRMH761 recovered after growth without kanamycin selection. It retains a single copy of IS*26* surrounded by a duplication of 119447 to 119454 bp in GenBank accession no. [KF976462](KF976462). pRMH761 (Ap^r^ Km^r^ Nm^r^) has been described previously ([@B12]) and consists of an 8.8-kb BamHI fragment from pRMH760 (bases 117841 to 126672 in GenBank accession no. [KF976462](KF976462)) containing Tn*4352*B (Km^r^ Nm^r^) cloned into pUC19 (Ap^r^). An IS*26* transposase knockout was generated by digesting pRMH762 with BsiWI, unique to the IS*26* ([Fig. 2](#fig2){ref-type="fig"}), followed by end filling with T4 DNA polymerase and religation. This introduced a 4-bp duplication of bases 114 to 117 relative to the left end of IS*26* (as shown in [Fig. 2](#fig2){ref-type="fig"}) and a frameshift in the *tnp26* gene leading to premature termination at a stop codon (bases 154 to 156 in IS*26*) forming a 30-aa protein. This form was designated IS*26*-FS-L, to indicate the location of the frameshift at the left-hand end of *tnp26*.

###### 

Plasmids used in this study

  Plasmid              Description                                             Resistance phenotype^[*a*](#ngtab4.1)^   Reference
  -------------------- ------------------------------------------------------- ---------------------------------------- ------------
  R388                 IncW plasmid                                            Su Tp                                    [@B42]
  R388::IS*26*         R388 with IS*26*^[*b*](#ngtab4.2)^                      Su Tp                                    This study
  R388::IS*26*-FS--R   R388::IS*26* frameshift mutant^[*c*](#ngtab4.3)^        Su Tp                                    This study
  pRMH761              8.8-kb BamHI fragment of pRMH760 cloned into pUC19      Ap Km Nm                                 [@B12]
  pRMH762              pRMH761 Km^s^ derivative^[*d*](#ngtab4.4)^              Ap                                       This study
  pRMH962              pRMH762 *tnp26* FS-L mutant^[*e*](#ngtab4.5)^           Ap                                       This study
  pRMH977              pRMH762 derivative^[*f*](#ngtab4.6),[*g*](#ngtab4.7)^   Ap                                       This study
  pRMH978              pRMH977 *tnp26* FS-L mutant^[*e*](#ngtab4.5)^           Ap                                       This study
  pRMH979              pRMH762 derivative^[*f*](#ngtab4.6),[*h*](#ngtab4.8)^   Ap                                       This study
  pRMH987              pRMH977 Tnp26 mutant D82L                               Ap                                       This study
  pRMH988              pRMH977 Tnp26 mutant D142L                              Ap                                       This study
  pRMH989              pRMH977 Tnp26 mutant E177L                              Ap                                       This study

Ap, ampicillin; Km, kanamycin; Nm, neomycin; Su; sulfamethoxazole; Tp, trimethoprim.

IS*26* 8-bp duplication of bases 26745 to 26752 in R388 (GenBank accession no. [BR000038](BR000038)).

Lacks 13 bp (bases 624 to 636 from the left end of IS*26*, as shown in [Fig. 5](#fig5){ref-type="fig"}).

Loss of *aphA1* and one IS*26* after overnight growth without kanamycin selection.

Frameshift generated by end filling the BsiWI site and duplicating 116 to 119 bp from the left end of IS*26* as shown in [Fig. 5](#fig5){ref-type="fig"}.

IS*26* together with bases 119362 to 119454 and 122137 to 122225 from GenBank accession no. [KF976462](KF976462).

Cloned insert in the same orientation as pRMH762, with *tnp26* facing toward P~lac~ in pUC19.

Cloned insert in the opposite orientation to pRMH762, with *tnp26* facing away from P~lac~ in pUC19.

R388::IS*26*, an R388 derivative containing a single copy of IS*26*, was created from an R388::pRMH762 cointegrate via digestion with SwaI to excise the fragment located between the two IS*26*s followed by religation. R388::IS*26* contains a single IS*26* with an 8-bp duplication of bases 26745 to 26752 in R388 (GenBank accession no. [BR000038](BR000038)). A frameshift was introduced into the *tnp26* gene in R388::IS*26* by digesting plasmid DNA with SwaI ([Fig. 2](#fig2){ref-type="fig"}) and treating it with 5 U of exonuclease III for 30 s to remove a small number of bases. Then the DNA was treated with 10 U of mung bean nuclease for 30 min at 30°C to generate blunt ends. The DNA was religated and transformed into chemically competent *E. coli* DH5α cells. Purified DNA was prepared from five transformants and digested with SwaI to confirm that the SwaI site had been removed by the exonuclease treatment. One transformant was selected, and sequencing of the amplicon generated by primers RH1471 and RH1472 revealed a 13-bp deletion in *tnp26*, removing bases 624 to 636 relative to the left end of IS*26*. This causes a frameshift at aa 186 in Tnp*26*, leading to a 187-aa protein, designated IS*26-*FS--R, to indicate its position near the 3′-end of *tnp26.*

As pRMH762 (9,656 bp) is too large to use with available site-directed mutagenesis kits, a smaller derivative, pRMH977 (3,695 bp), was constructed by amplifying and recloning the IS*26* from pRMH762. The IS*26* together with bases 119362 to 119454 and 122137 to 122225 from GenBank accession no. [KF976462](KF976462) was amplified with primers RH1451 and RH1452, which contain a BamHI site at their 5′ ends, to facilitate cloning into BamH1-digested, phosphatase-treated pUC19 vector. The size and orientation of inserts were determined in 10 transformants by digestion with PstI and NdeI. A transformant with the insert in the same orientation as pRMH762 (*tnp26* facing toward the pUC19 P~lac~) (pRMH977), and a transformant with the insert in the opposite orientation (pRMH979) were retained. The codons for the DDE residues ([Fig. 2](#fig2){ref-type="fig"}) predicted to be conserved ([@B2]), were substituted in pRMH977 using a QuikChange II site-directed mutagenesis kit (Agilent Technologies) according to the manufacturer's instructions. The two aspartic acid residues at positions 82 and 142, and the glutamic acid residue at position 177 in Tnp*26* were changed to a leucine residue via site-directed mutagenesis using primer pairs RH1456/RH1457, RH1476/RH1477, and RH1458/RH1459 to generate clones pRMH987, pRMH988, and pRMH989, respectively. The amino acid substitution was confirmed by PCR amplification of IS*26* and sequencing.

Transposition assays. {#h3.4}
---------------------

Strains for transposition assays were generated via conjugation of either R388 (Su^r^ Tp^r^) or R388::IS*26* (Su^r^ Tp^r^) into *E. coli* DH5α cells containing the nonconjugative plasmid pRMH762 (Ap^r^) or pRMH977 (Ap^r^) or one of their derivatives. Cointegrate formation was assessed by mating these strains with UB1637 (Sm^r^) and selecting for Ap^r^ Sm^r^ Tp^r^ colonies. Transposition frequency was calculated as the number of Ap^r^ Tp^r^ transconjugants (cointegrates) per Tp^r^ Sm^r^ transconjugant (R388 or R388::IS*26*).

To determine the positions of cointegrate junctions in the R388 backbone, plasmid DNA isolated from two colonies from each of 10 independent transposition experiments was digested overnight with BsiWI and BglII. The presence of a BsiWI site in each IS*26* and two BsiWI and BglII sites in the R388 backbone allowed the determination of the approximate location of cointegrate formation between R388 and the IS*26*-containing plasmid. Targeted cointegrate formation in R388::IS*26* was detected by restriction mapping as described above, combined with a PCR mapping strategy that linked the DNA originating from the IS*26*-containing plasmid across each IS*26* into the R388 backbone using primer pairs RH1471/1452 and RH1472/RH1451.
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